introduction: Infiltration of the central nervous system (CNS) by hematologic or lymphoid malignant cells can cause extensive neurological damage, be progressive and fatal. However, usually, the cerebrospinal fluid (CSF) has low cellularity and rapid cell degeneration, which can impair cytometry analysis. Storage and transport measures, sample preparation, and staining protocols can interfere with diagnostic accuracy.
introduction: Infiltration of the central nervous system (CNS) by hematologic or lymphoid malignant cells can cause extensive neurological damage, be progressive and fatal. However, usually, the cerebrospinal fluid (CSF) has low cellularity and rapid cell degeneration, which can impair cytometry analysis. Storage and transport measures, sample preparation, and staining protocols can interfere with diagnostic accuracy.
Objective: To calculate the diagnostic performance of flow cytometry (FC) using a cell stabilizer for sample preservation compared to cytomorphology in the detection of CNS infiltration by lymphoid and hematologic neoplasms.
Methods: Cell samples from all consecutive patients with suspected infiltration by hematological malignancies evaluated between January 2014 and December 2016 were included. Cases were analyzed by FC using a cell preservation medium and cytomorphology. Sensitivity and specificity were calculated.
results: From 414 CSF samples, 72 had a phenotype compatible with characteristics of infiltration by hematological disease, whereas cytology was positive for 35 cases. FC showed higher sensitivity and specificity when compared to cytomorphology, particularly in cases with cellularity under 5 leukocytes/mm -CD8  UCHT-4  CD38  T16  Cytognos  PE  CD56  N901  CD56  N901  CD4  N901  CD56  N901  Cytognos  PERCP-Cy5.5  CD34  8G12  CD34  8G12  CD34  8G12   a   -BD  PC7  CD19  J3-119  CD117  104D2D1  CD19  J3-119  CD19  J3-119  BC  APC  CD3  + CD14  SK7/MφP9  CD3  + CD14  SK7/MφP9  CD3  + CD14  SK7/MφP9  CD3  + CD14  SK7/MφP9  BD  APC-H7  CD10  HB7  CD38  HB7  CD38  HB7   a   -BD  V450  CD20  L27  CD20  L27  CD3cy  UCHT1  CD45  2D1  BD  V500  CD45  2D1  CD45  2D1  CD45  2D1  CD138  MI15 The involvement of the central nervous system (CNS) by hematologic malignancies is considered a major complication in patients with B-or T-cell lymphomas and in patients with acute lymphoid or myeloid leukemia (1) . Neoplastic cell infiltration into the CNS may cause extensive neurological damage and can be progressive and fatal if it is not detected in time (2, 3) . Meningeal infiltration by neoplastic cells occurs in approximately 5-15% of patients with leukemia and lymphoma (4) . The involvement of the CNS can occur through dissemination of neoplastic cells through arteries, perineural and perivascular spaces, and infiltration of malignant cells from solid tumors (4) (5) (6) . Currently, the main tools used for detection of CNS infiltration by neoplastic cells include neurological clinical assessment, neuroimaging studies, and cytomorphology (7) . Symptoms of CNS infiltration may be present in several conditions other than hematologic malignancies, the clinical manifestations are late and usually occur in advanced stages of disease (7) . Some neuroimaging techniques, such as magnetic resonance imaging, are sensitive but have low specificity (8) . Cytological examination of the cerebrospinal fluid (CSF) is considered a gold standard technique; however, it has low sensitivity with false positive results ranging from 20 to 60%, especially in low-cellularity samples (9, 10) , which can delay diagnosis and the correct treatment of patients (7, 11) .
Laboratory techniques with greater accuracy and sensitivity include molecular biology, molecular genetics, and flow cytometry (FC) (7, 12) . FC complements cytology as a technique to test the CSF (3, (13) (14) (15) . Cytometry can enhance the possibility of diagnosing lymphomas in the CSF, because it is able to detect abnormal cells in samples containing only 0.9% of monoclonal B-lymphocytes (2, 16, 17) . Currently, in patients with clinical suspicion of CNS infiltration by neoplastic cells, cytology, and immunophenotyping by FC are the techniques recommended by the National Comprehensive Cancer Network (18) .
Recent advances have shown that the use of multiparameter FC, such as 10-parameter single-tube detection, has considerably increased the specificity and sensitivity in detecting cells with abnormal phenotypes (1, 14, 15, 17, 19) . Nonetheless, in most cases, the CSF has low cellularity with rapid cell degeneration. Therefore, recent studies have suggested some storage and transport guidelines, as well as sample preparation and staining protocols, to improve the quality of results (1) .
Objective
The purpose of this diagnostic accuracy study is to evaluate the diagnostic performance of FC using a cell stabilizer for sample preservation compared to cytomorphology in the detection of CNS infiltration by lymphoid and hematologic neoplasms.
MaTerials anD MeThODs study Design, Participants, and ethics
This is a diagnostic accuracy study of FC results compared to cytomorphology as the gold standard technique, in the diagnosis of CNS infiltration by neoplastic cells. Participants were all patients who had their tissue samples tested by FC between January 2014 and December 2016 in the same institution. To be included in this study, patients should have clinical suspicion or be under follow up for hematological malignancy, or they suffered from neurological conditions, such as encephalitis, epilepsy, seizures, among others (the study of the CSF was performed to rule out any hypothesis of oncohematological disease). All patients underwent examination of CSF cells by FC.
The Institutional Review Board reviewed the study protocol and approved the use of data collected for this study. The human tissue and fluid samples analyzed were obtained from patients routinely subjected to immunophenotyping in a clinical FC + (3,385 events) was 68.6% CD3 T-lymphocytes-in that, 52.6% CD4 T-lymphocytes and 13.9% CD8 T-lymphocytes; 0.9% NK cells; 0.7% mature and polyclonal B-lymphocytes (kappa/lambda ratio: 2.38); and 29.8% monocyte lineage cells. laboratory for diagnosis of hematologic neoplasms, irrespective of this study. The study did not offer any direct benefits to patients or interfere with patient diagnosis or treatment.
Procedures
In order to preserve and prolong cell viability, the samples submitted for immunophenotyping were collected in cell stabilizer Transfix, in a tube containing the anticoagulant ethylenediaminetetracetic acid (EDTA), observing the ratio of 1:10 Tranfix/CSF and a volume ranging between 3 and 5 ml.
In cases of suspected lymphoproliferative disease and other clinical conditions, the staining strategy initially used for immunophenotyping was the Euroflow Small Sample Tube, with the antibodies shown in Table 1 . Patients with suspected infiltration by acute myeloid leukemia (AML), multiple myeloma, and acute B-and T-cell lymphoid leukemia were stained according to Table 2 . All antibodies were standardized, titrated, and validated by our laboratory.
cytomorphology and Fc
The cell count was performed approximately 30 min after puncture using a Fuchs-Rosenthal chamber and sample cellularity ranged between 0 and 908 cells/μl.
For slides preparation, we used cytocentrifugation at 1,000 rpm, for 5 min, using 200 μl of fresh CSF samples. Samples were stained according to the Leishmann method. Each case was interpreted by an experienced cytomorphologist who was unaware of the results of FC. Samples were considered negative in the absence of morphologically anomalous population. The results were considered positive when there was the presence of cells with atypical characteristics, such as high nucleus cytoplasm and presence of nucleolus.
According to the standard technical procedure, the cell samples were then centrifuged, now at a speed of 1,100 rpm, for 10 min, washed with 10 ml of phosphate buffer saline (PBS) + 2% fetal bovine serum (FBS). For clinical suspicion of infiltration of mature B-cell neoplasms, the washing procedure was repeated to eliminate proteins, which could interfere in detection of clonality with kappa and lambda light chain, and/or prevent unspecific staining.
The cell pellet was then stained with fluorochrome conjugates of monoclonal antibodies, and incubated for 20 min, at room temperature, and protected from light. Red blood cell lysis was performed (whenever necessary) with an ammonium chloride buffer for 5 min; cells were washed with 3 ml PBS + 2% FBS and resuspended in 0.5 ml PBS. Finally, the stained samples were immediately acquired in the Becton Dickinson FACS Canto II flow cytometer. Data analysis was performed using the Infinicyt software (Cytognos).
statistical analysis
Cytomorphology and FC results were compared using absolute and relative frequencies, and the agreement between methods was verified using kappa and diagnostic measures (sensitivity and specificity) (20 
Patients
Of the patients, 306 were clinically suspected of or being followed up for hematological malignancy, and 108 had other clinical conditions, such as encephalitis, epilepsy, seizures, among others. Of the 414 samples tested, 342 showed no immunophenotypic changes suggestive of CNS infiltration by hematological malignancies. Even in 335 samples who had low cellularity (<5 cells/μl) defined by the Fuchs-Rosenthal global chamber count, FC was able to detect T-, B-, natural killer (NK)-lymphocytes, and monocytes ( Table 3) .
negative Fc results
Comparing the 342 negative FC samples (Figure 1) with the morphological samples, 304 were also negative in the cytomorphological test. Only 2 samples showed positive cytomorphology for neoplastic cells, while 9 had inconclusive results in the same test. Morphological testing was not possible in 3 samples due to low cellularity, and 24 samples were missing an order for chemical and cytological analyses.
Positive Fc results
Immunophenotypic abnormalities suggestive of CNS infiltration by hematological malignancies were found in 72 cases studied. Among the positive cases, 33 samples were classified as non-Hodgkin B-cell lymphoma (B-NHL, Figure 2) ; 10 as B-cell lymphoblastic leukemia ( Figure 3) ; 1 blastic plasmacytoid dendritic cell neoplasm; 9 with T-cell lymphoblastic leukemia ( Figure 4) ; 2 T/NK-cell lymphoblastic leukemia; 4 blastic plasmacytoid dendritic cell neoplasms, and 13 showed abnormal immature myeloid population (AML) (Figure 5) . In respect to the 72 positive FC samples, 35 were also positive on the cytomorphology test, 2 were inconclusive, 29 were negative, 1 sample was not processed due to low cellularity, and in 5 cases, there were no samples available because the attending physician did not fill in the request for chemical and cytological testing. Interestingly, the CNS infiltration by hematological malignancies was identified even in samples with <5 cells/μl that represented 55.6% (40/72) of positive FC tests (p < 0.001, Figure 6 ). Furthermore, in these 40 positive FC samples, 57.5% (23/40) had negative cytomorphology tests.
In the study of 414 cases, 370 presented positive or negative results for FC and cytomorphology. FC showed higher sensitivity and specificity for 370 samples when compared to cytomorphology, particularly in cases with cellularity under 5 leukocytes/mm 
DiscUssiOn
This study reports the technical improvements made to increase test accuracy, sample stability, and compare CSF analysis by FC and cytomorphology. The technical procedures of FC have been recently improved aiming to increase test reliability and make better use of samples. Our study showed that 72 samples had a phenotype compatible with infiltration by hematologic disease, whereas cytology was positive in 35 cases. Thus, FC was much more accurate and sensitive when compared with cytomorphology, primarily in low-cellularity and low-volume samples. The investigation of CSF infiltration by hematologic neoplasms by conventional morphologic study has low sensitivity even when associated with neuroimaging studies, as well as neurological signs and symptoms. Despite the high specificity of cytomorphology, the literature reports false negative results range between 20 and 60% (2, 16, 21) . Currently, conventional cytology tests yield positive results for neoplastic cells at concentrations starting at 5% (22) . However, the cytomorphological analysis may be impaired because of the paucity of cells in CSF. Moreover, the identification of neoplastic cells in CSF can be a challenge due to similarities between benign and malignant cells. Several studies have demonstrated a significant increase in sensitivity of meningeal infiltration detection in patients with hematologic malignancies when the samples are evaluated by FC comparing the cytomorphology, ratifying the importance of immunophenotyping in CSF analysis (21, (23) (24) (25) .
Due to higher sensitivity, FC is important to detect occult or subclinical CNS involvement during maintenance therapy and clinical follow-up, especially when cytomorphology is negative. The detection of subclinical CNS involvement is associated with poor prognosis and a higher risk of relapse in acute lymphoblastic leukemia and B-cell lymphomas (2, 16, 24, 26) . However, FC still has some limitations for CSF testing due to low cellularity, aggravated by small samples and poor cell viability. In addition to these limitations, peripheral blood contamination could alter results, and it is very difficult to identify. Thus, CSF immunophenotyping requires specific technical procedures to be correctly conducted (1) . In our data, 6 samples of 72 positive cases by FC were suggestive of contamination, and despite this, the ability to detect neoplastic cells in CSF by FC is greater than cytomorphology regardless of whether the cells are primary of the CNS or the result from peripheral blood contamination by puncture trauma. We know that this possibility of contamination is aggravated at the time of diagnosis of acute leukemias, when the neoplastic cells circulating in the peripheral blood may be in greater numbers. However, in the central neural system post-treatment evaluations of acute leukemias, the presence of circulating neoplastic cells is rare, which may indicate that the immunophenotypic findings suggest CNS infiltration and not contamination of the material at this clinical time.
In our study, FC was able to identify no neoplastic CSF cells and infiltrating neoplastic cells even in samples with lowcellularity and low-volume that represented 75.1% of our samples (Figure 7) . Interestingly, even in CSF with no cells defined by Fuchs-Rosenthal chamber count, FCM was able to detect T-, B-, NK-lymphocytes, and monocytes ( Table 3) . As expected, the detection capability is proportional to CSF cells concentration. Our data showed that in a CSF with 2 cells/μl all T-cells and monocytes can be identified, and for NK-, B-lymphocytes the cellularity requirement varies between 3 and 5 cells/μl.
Altogether, these results support previous observations that FC is more sensitive than cytomorphology (2, 21) , and that FC was able to detect CSF disease more frequently than cytomorphology (16) . In this study, FC could detect CSF involvement in 11 samples while cytomorphology was able to detect only 1 case. The explanation to the higher sensitivity is that cytomorphology shows positive or suspicious results only in samples with increased cellularity. All this progress has been possible due to technical standardization for better cell concentration in a single tube, and updating of our immunophenotyping protocol, from 4 to 8 colors and 13 parameters. A better cell concentration provided satisfactory results even in samples with low cellularity and the change in immunophenotyping protocol allowed the staining in a single tube, increasing sensibility. The use of analysis software, such as Infinicyt, enabled a more accurate and reproducible data analysis, removing interfering factors, such as doublets, degenerated cells, and unspecific staining. Moreover, the use of the cell stabilizer Transfix allowed the receipt of samples from distant centers, avoiding stability problems. However, the cell stabilizer cannot be used for morphological analysis. One of the major challenges faced by laboratories in CSF processing is rapid cell degeneration in samples. Thirty minutes after collection, the cell count starts to decrease significantly (27) . The use of collection media is recommended to solve this problem (1). The two media used by most laboratories are the Roswell Park Memorial Institute medium and Transfix (Cytomarl, UK).
Transfix is a stabilizer that prevents cell loss and reduces autofluorescence. Some studies showed that using Transfix in CSF samples prevents cell loss and allows the sample to be stored for 18-72 h until it is processed (1, 27) . Moreover, the complexity features of lymphocytes are maintained, cell autofluorescence decreases, and cell fixation does not interfere with monoclonal antibody staining. However, there is a decrease in the size and complexity of granulocyte and monocyte populations in case of prolonged storage in Transfix, which could hinder cytomorphological testing (27) . FC is a powerful and sensitive technique for testing CSF with suspected infiltration of lymphoma or leukemia. With all these improvements, it was possible to increase the accuracy and sensitivity of the detection of B-and T-lymphocytes, and their subtypes (CD3 Our data corroborate the literature findings and allow us to conclude that FC is a highly sensitive tool for detection of hematologic neoplasms cells in CSF, especially in low-level CNS involvement. This information could be useful for close monitoring of patients, changes in therapy strategy, and identify patients with high risk of relapse.
cOnclUsiOn
In this study, we demonstrated that the CSF can be used for disease detection and screening of major leukocyte populations, even in low-volume and low-cellularity samples. This is possible if the sample is collected in a medium that preserves sample stability, immunophenotyping is performed with technical procedures specific for CSF samples, if appropriate immunophenotyping panels and a flow cytometer with 8-color/13-parameter configuration are used, as well as modern data analysis software.
eThics sTaTeMenT
The Institutional Review Board reviewed the study protocol and approved the use of data collected for this study. The human tissue and fluid samples analyzed were obtained from patients routinely subjected to immunophenotyping in a clinical flow cytometry laboratory for diagnosis of hematologic neoplasms, irrespective of this study. The study did not offer any direct benefits to patients or interfere with patient diagnosis or treatment. For blinding purposes, the ethics committee name was removed from the submitted text. However, the IRB that evaluated the study is Hospital Israelita Albert Einstein (HIAE), in São Paulo, Brazil.
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